Is Poseida Therapeutics Inc (PSTX) Stock at the Top of the Biotechnology Industry?

The 62 rating InvestorsObserver gives to Poseida Therapeutics Inc (PSTX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 81 percent of stocks in the Biotechnology industry, PSTX’s 62 overall rating means the stock scores better than 62 percent of all stocks.

PSTX has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on PSTX!

See Full PSTX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Poseida Therapeutics Inc Stock Today?

Poseida Therapeutics Inc (PSTX) stock is up 0.47% while the S&P 500 is down -0.08% as of 11:39 AM on Friday, Nov 17. PSTX has gained $0.01 from the previous closing price of $2.15 on volume of 241,780 shares. Over the past year the S&P 500 is higher by 14.14% while PSTX is down -52.21%. PSTX lost -$1.50 per share the over the last 12 months. Click Here to get the full Stock Report for Poseida Therapeutics Inc stock.